Prediction of COPD and Related Events Improves by Combining Spirometry and the Single Breath Nitrogen Test

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 15, Issue 5, 2018, Pages 424-431

  Olofson, Jan ^a   Bake, Björn ^a   Bergman, Bengt ^a   Ullman, Anders ^b   Svärdsudd, Kurt ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

COPD event; Epidemiology; longitudinal study; respiratory functions tests

Indexed keywords

ADULT; AGE; ANTHROPOMETRY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CORRELATION ANALYSIS; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LONGITUDINAL STUDY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SINGLE BREATH NITROGEN TEST; SMALL AIRWAY DISEASE; SMOKING HABIT; SPIROMETRY; AGED; AIRWAY RESISTANCE; BREATH ANALYSIS; HOSPITALIZATION; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; REGISTER; SMOKING; SWEDEN; VERY ELDERLY;

NITROGEN;

AGED; AGED, 80 AND OVER; AIRWAY RESISTANCE; BREATH TESTS; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NITROGEN; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; SMOKING; SPIROMETRY; STATISTICS, NONPARAMETRIC; SWEDEN;

EID: 85059913265     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412555.2018.1538330     Document Type: Article

References (34)

1. Hogg JC, Macklem PT, Thurlbeck WM, Path MC. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278(25):1355–1360
2. Hogg JC, Chu F, Utokaparch S, Woods R, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–2653
3. Hogg JC, Chu FS, Tan WC, et al. Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med. 2007;176(5):454–459
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2018 report. Available from: http://www.goldcopd.org/.,
5. Garcia-Aymerich J, Serra Pons I, Mannino DM, Maas AK, Miller DP, Davi KJ. Lung function impairment, COPD hospitalisations and subsequent mortality. Thorax. 2011;66(7):585–590
6. Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, Macklem PT. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978;298(23):1277–1281
7. Oxhöj H, Bake B, Wilhelmsen L. Ability of spirometry, flow-volume curves and the nitrogen closing volume test to detect smokers. A population study. Scand J Respir Dis. 1977;58(2):80–96
8. Olofsson J, Bake B, Svärdsudd K, Skoogh BE. The single breath N2-test predicts the rate of decline in FEV1. The study of men born in 1913 and 1923. Eur J Respir Dis. 1986;69(1):46–56
9. Vestbo J, Knudsen KM, Rasmussen FV. Predictive value of the single-breath nitrogen test for hospitalization due to respiratory disease. Lung. 1990;168(2):93–101
10. Olofson J, Bake B, Bergman B, Svärdsudd K. The single breath nitrogen test and mortality—a 38 years follow up. Respir Med. 2016;112:75–80
11. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187
12. 2 -test and spirometry in healthy non-smoking males. Eur J Respir Dis. 1984;65(4):296–304
13. Buist AS, Vollmer WM, Johnson LR, McCamant LE. Does the single-breath N2 test identify the smoker who will develop chronic airflow limitation? Am Rev Respir Dis. 1988;137(2):293–301
14. Stănescu DC, Rodenstein DO, Hoeven C, Robert A. “, Sensitive tests” are poor predictors of the decline in forced expiratory volume in one second in middle-aged smokers. Am Rev Respir Dis. 1987;135(3):585–590
15. Stănescu D, Sanna A, Veriter C, Robert A. Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up. Chest. 1998;114(2):416–425
16. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–532
17. Quach A, Giovannelli J, Chérot-Kornobis N, Ciuchete A, Clément G, Matran R, Amouyel P, Edmé JL, Dauchet L. Prevalence and underdiagnosis of airway obstruction among middle-aged adults in northern France: the ELISABET study 2011-2013. Respir Med. 2015;109(12):1553–1561
18. Schembri S, Anderson W, Morant S, Winter J, Thompson P, Pettitt D, MacDonald TM, Winter JH. A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respir Med. 2009;103(10):1461–1467
19. Baughman P, Marott JL, Lange P, Martin CJ, Shankar A, Petsonk EL, Hnizdo E. Combined effect of lung function level and decline increases morbidity and mortality risks. Eur J Epidemiol. 2012;27(12):933–943
20. Müllerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, Bakke P, Agusti A, Anzueto A, ECLIPSE Investigators. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147(4):999–1007
21. Zaigham S, Wollmer P, Engström G. Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up. Eur Respir J. 2016;47(3):742–750
22. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–1575
23. Boeck L, Gensmer A, Nyilas S, Stieltjes B, Re TJ, Tamm M, Latzin P, Stolz D. Single-breath washout tests to assess small airway disease in COPD. Chest. 2016;150(5):1091–1100
24. Vikgren J, Friman O, Borga M, Boijsen M, Gustavsson S, Ekberg-Jansson A, Bake B, Tylén U. Detection of mild emphysema by computed tomography density measurements. Acta Radiol. 2005;46(3):237–245
25. Anthonisen NR, Robertson PC, Ross WR. Gravity-depende sequential emptying of lung regions. J Appl Physiol. 1970;28(5):589–595
26. Niu SF, Sixt R, Bake B. Non-uniform lung elastic properties and the slope of the alveolar plateau. Bull Eur Physiopathol Respir. 1987;23(2):163–169
27. Olofson JY, Houltz B, Nilsson Tengelin M, Bake B. Respiratory symptoms and peripheral airways disease in a cross-sectional study on a random population sample, BMJ Open 2012;2:e001488. doi:10.1136/bmjopen-2012-001488
28. Verbanck S, Schuermans D, Meysman M, Paiva M, Vincken W. Noninvasive assessment of airway alterations in smokers: the small airways revisited. Am J Respir Crit Care Med. 2004;170(4):414–419
29. Jetmalani K, Chapman DG, Thamrin C, Farah CS, Berend N, Salome CM, King GG. Bronchodilator responsiveness of peripheral airways in smokers with normal spirometry. Respirology. 2016;21(7):1270–1276
30. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130–139
31. Engström G, Melander O, Hedblad B. Population-based study of lung function and incidence of heart failure hospitalisations. Thorax. 2010;65(7):633–638
32. Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res. 2013;162(4):237–251
33. de Miguel Díez J, Chancafe Morgan J, Jiménez García R. The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis. 2013;8:305–312
34. Kee K, Stuart-Andrews C, Nilsen K, Wrobel JP, Thompson BR, Naughton MT. Ventilation heterogeneity is increased in patients with chronic heart failure. Physiol Rep. 2015;3(10). doi:10.14814/phy2.12590